The trademark AMOXICLAVAN was filed by VAN PHARMA B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on November 1, 2022, and received one opposition filed on January 29, 2023 by BIOGARAN, société par actions simplifiée on Likelihood of confusion. the opponent was represented by CABINET GERMAIN & MAUREAU and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 29, 2023
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).